Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
08/10/2026 08:59
BRIEF-Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln Oct 8 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST:
CALLS EGM ON OCT 5, 2026 FOR RIGHTS ISSUE OF UP TO 147.6 MSEK
SUBSCRIPTION PRICE IS 2.40 SEK PER UNIT, 0.60 SEK PER SHARE, WARRANT ISSUED FREE
ENTERS BRIDGE FINANCING AGREEMENTS TOTALING 30.7 MSEK
MAXIMUM OFFSET AMOUNT IN RIGHTS ISSUE ESTIMATED AT 48.7 MSEK IF BOARD APPROVES
ISSUE VOLUME UP TO 61,494,038 UNITS, CORRESPONDING TO 147.6 MSEK
Source text: ID:nWkr3l4vx6
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement